Progressive axonopathy when oligodendrocytes lack the myelin protein CMTM5.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 35274615.
- Also identified by DOI 10.7554/eLife.75523 and PMC identifier 8916772.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Oligodendrocytes facilitate rapid impulse propagation along the axons they myelinate and support their long-term integrity. However, the functional relevance of many myelin proteins has remained unknown. Here, we find that expression of the tetraspan-transmembrane protein CMTM5 (chemokine-like factor-like MARVEL-transmembrane domain containing protein 5) is highly enriched in oligodendrocytes and central nervous system (CNS) myelin. Genetic disruption of the <i>Cmtm5</i> gene in oligodendrocytes of mice does not impair the development or ultrastructure of CNS myelin. However, oligodendroglial <i>Cmtm5</i> deficiency causes an early-onset progressive axonopathy, which we also observe in global and tamoxifen-induced oligodendroglial <i>Cmtm5</i> mutants. Presence of the <i>Wld<sup>S</sup></i> mutation ameliorates the axonopathy, implying a Wallerian degeneration-like pathomechanism. These results indicate that CMTM5 is involved in the function of oligodendrocytes to maintain axonal integrity rather than myelin biogenesis.
Medical subject headings
- Myelin Sheath
- Oligodendroglia